Cytokines are small cell signaling protein molecules involved in cellular communication, immune response, inflammation and hematopoiesis. Assays kits allow for the detection of these molecules for research and clinical purposes. Studying cell signaling via assay systems is reliable and effective when the right detection mechanism is utilized. Mouse, human, and rat detection cytokine detection assays are available for comparison in type, price, and suitability. ELISA assay kits for human interleukins (IL), ELISpot assays for rat interferons (IFN), and arrays for mouse general inflammation detection using cell culture or sera samples are listed according to detection method. Important features to look for in cytokine assay are sensitivity, broad dynamic range and quality of the antibody pairs’ affinity and specificity.
The role of 3'-5'-cyclic adenosine monophosphate (cAMP) as a second messenger in...
The eBioscience mouse IL-10 Ready-SET-Go-ELISA kit comes in different formats ...
Monday, November 05, 2012
Multiplex technology allows researchers to explore the regulation of small molecules -- like ...
Thursday, August 04, 2011
Cytokines are vital intercellular communication molecules. These proteins carry signals or messages ...
Wednesday, February 03, 2010
This presentation introduces Quansys Bioscience’s Q-Plex™ technology and how it's multiplex ELISA platform can be applied to save users sample, time, and money.
Wednesday, December 30, 2009
The MultiBead™ bead-based multiplex assay platform has been expanded to now offer 20 common human markers of inflammation. Customize your own uPlex kit or pathology-related pathPlex panel, conveniently run samples on a flow cytometer, and analyze ...
Description/Abstract: Assay Designs/Stressgen Bioreagent’s exclusive bead-based multiplex assay for Heat Shock Protein and Molecular Chaperone analysis using MultiBead® technology: conveniently run samples on a flow cytometer and analyze with our ...
Wednesday, January 23, 2013
Instead of focusing on the elimination of cancer cells, maintaining a stable population of healthy blood cells in the bone marrow could be the most ...
Monday, December 24, 2012
Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the ...
Wednesday, January 11, 2012
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from ...